Developing methods to transfer nitrogen atoms for new medical treatments
Selective Nitrogen Atom Transfer for Applications in Biomedical Sciences
This study is looking at new ways to add nitrogen to organic molecules, which is important for making better medicines and tools for studying diseases, using special techniques that involve iron to make the process more effective and precise.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brandeis University NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project ID | NIH-10863808 on NIH RePORTER |
What this research studies
This research focuses on creating innovative methods for transferring nitrogen atoms to organic molecules, which is crucial for developing new therapeutic drugs and biological probes. By exploring novel reaction mechanisms and utilizing iron catalysis, the project aims to enhance the selectivity and effectiveness of nitrogen atom transfer processes. This could lead to the synthesis of complex molecules that are essential in biomedical applications, ultimately improving drug discovery and development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from new therapeutic agents developed through advanced synthetic methods.
Not a fit: Patients who are not seeking new treatment options or those with conditions that do not involve nitrogen-containing therapeutic agents may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective and targeted therapeutic agents for various medical conditions.
How similar studies have performed: Other research in the field of nitrogen atom transfer and organic synthesis has shown promising results, indicating that this approach could lead to significant advancements in medicinal chemistry.
Where this research is happening
Waltham, United States
- Brandeis University — Waltham, United States (Active)
Researchers
- Principal investigator: Xu, Hao — Brandeis University
- Study coordinator: Xu, Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.